ArticleScientific reports2026
BMA-YOLO: an object detection model for microscopic images of mouse embryos.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
In vitro embryo culture is a pivotal technology in life sciences and medical research. However, automated monitoring remains challenging due to factors such as bubble interference and the frequent omission of small or peripheral embryos. To overcome these limitations, this study introduces BMA-YOLO, an enhanced model built upon the YOLOv8 architecture. By integrating BiFormer and Multi-Scale Attention Aggregation (MSAA) mechanisms, the model strengthens its capacity for feature extraction and multi-level feature fusion. Furthermore, a detection head specifically designed to capture small objects is incorporated to improve sensitivity toward diminutive embryos. Experimental results on a private embryo dataset demonstrate that BMA-YOLO achieves an mAP50 of 96.94%, an mAP50-95 of 69.26%, and a recall rate of 94.20%. Compared with the baseline model, these results correspond to improvements of 3.57%, 3.30%, and 6.69%, respectively. BMA-YOLO effectively mitigates bubble interference and significantly enhances the detection performance for small and peripheral embryos, providing robust algorithmic support for subsequent automated monitoring systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.